Session Details

Moderator

David Cescon, Princess Margaret Cancer Centre/UHN, Toronto, ON, Canada

Presentation numberCT2-01

Is MRD Ready for Prime Time?

Nick Turner, Royal Marsden, London, United Kingdom

Presentation numberCT2-02

ctDNA Guided Endpoints in Metastatic Disease

Jo Chien, UCSF, San Francisco, CA

Presentation numberCT2-03

Endpoints in Modern Clinical Trials

Yu Shyr, Vanderbilt University School of Medicine, Nashville, TN

Presentation numberCT2-04

Navigating MRD Testing: Partnering with Patients to Optimize Care

Patricia A Spears, University of North Carolina, Chapel Hill, NC